Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Kruppel like factor 6 | 0.501 | 0.846 | 0.98 |
|
group | 0.400 | None | 1.000 | 0 | 0 | 2001 | 2013 | ||||||||
|
MAX interactor 1, dimerization protein | 0.547 | 0.615 | 1.1E-03 |
|
group | 0.360 | None | 1.000 | 0 | 0 | 1995 | 2001 | ||||||||
|
mitotic arrest deficient 1 like 1 | 0.570 | 0.731 | 6.8E-16 |
|
group | 0.300 | None | 0 | 0 | |||||||||||
|
BRCA2 DNA repair associated | 0.379 | 0.846 | 2.4E-25 |
|
group | 0.580 | None | 1.000 | 1 | 0 | 2000 | 2018 | ||||||||
|
cyclin D1 | 0.344 | 0.923 | 0.89 |
|
group | 0.570 | None | 1.000 | 1 | 0 | 1999 | 2015 | ||||||||
|
transforming growth factor beta receptor 2 | 0.413 | 0.846 | 0.13 |
|
group | 0.540 | None | 1.000 | 1 | 0 | 2004 | 2018 | ||||||||
|
retinoid X receptor alpha | 0.543 | 0.769 | 1.00 |
|
group | 0.510 | None | 1.000 | 1 | 0 | 2004 | 2008 | ||||||||
|
KRAS proto-oncogene, GTPase | 0.320 | 0.923 | 7.9E-04 |
|
group | 0.500 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
clusterin | 0.426 | 0.885 | 7.8E-05 |
|
group | 0.400 | None | 1.000 | 1 | 0 | 1996 | 2019 | ||||||||
|
early growth response 1 | 0.433 | 0.923 | 0.35 |
|
group | 0.400 | None | 1.000 | 1 | 0 | 2002 | 2013 | ||||||||
|
epidermal growth factor | 0.357 | 0.923 | 8.5E-17 |
|
group | 0.400 | None | 1.000 | 1 | 0 | 1990 | 2009 | ||||||||
|
C-X-C motif chemokine ligand 12 | 0.379 | 0.846 | 0.12 |
|
group | 0.400 | None | 1.000 | 1 | 0 | 2002 | 2012 | ||||||||
|
vitamin D receptor | 0.352 | 0.885 | 1.7E-05 |
|
group | 0.400 | None | 1.000 | 1 | 0 | 2002 | 2018 | ||||||||
|
elaC ribonuclease Z 2 | 0.670 | 0.346 | 1.7E-20 |
|
group | 0.400 | None | 1.000 | 1 | 0 | 2001 | 2008 | ||||||||
|
zinc finger BED-type containing 1 | 0.716 | 0.423 | 3.6E-04 |
|
group | 0.400 | None | 1.000 | 1 | 0 | 2003 | 2019 | ||||||||
|
hypoxia inducible factor 1 subunit alpha | 0.327 | 0.923 | 0.98 |
|
group | 0.400 | None | 1.000 | 1 | 0 | 2002 | 2019 | ||||||||
|
BCL2 apoptosis regulator | 0.291 | 0.885 | 0.56 |
|
group | 0.400 | None | 1.000 | 1 | 0 | 1999 | 2018 | ||||||||
|
matrix metallopeptidase 9 | 0.305 | 0.923 | 1.9E-17 |
|
group | 0.400 | None | 1.000 | 1 | 0 | 2002 | 2017 | ||||||||
|
BRCA1 DNA repair associated | 0.367 | 0.923 | 9.2E-29 |
|
group | 0.400 | None | 1.000 | 1 | 0 | 1998 | 2013 | ||||||||
|
parathyroid hormone like hormone | 0.453 | 0.846 | 0.81 |
|
group | 0.390 | None | 1.000 | 1 | 0 | 1999 | 2013 | ||||||||
|
prostate stem cell antigen | 0.555 | 0.615 | 0.17 |
|
group | 0.380 | None | 1.000 | 1 | 0 | 2001 | 2018 | ||||||||
|
checkpoint kinase 2 | 0.460 | 0.808 | 1.2E-24 |
|
group | 0.370 | None | 1.000 | 1 | 0 | 2003 | 2008 | ||||||||
|
membrane metalloendopeptidase | 0.407 | 0.808 | 1.5E-18 |
|
group | 0.370 | None | 1.000 | 1 | 0 | 2003 | 2008 | ||||||||
|
macrophage scavenger receptor 1 | 0.553 | 0.654 | 2.2E-20 |
|
group | 0.370 | None | 1.000 | 1 | 0 | 2002 | 2007 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta | 0.322 | 0.885 | 1.00 |
|
group | 0.370 | None | 1.000 | 1 | 0 | 2006 | 2018 |